A detailed history of Benjamin F. Edwards & Company, Inc. transactions in Alcon Inc stock. As of the latest transaction made, Benjamin F. Edwards & Company, Inc. holds 2,698 shares of ALC stock, worth $241,605. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,698
Previous 2,647 1.93%
Holding current value
$241,605
Previous $207,000 8.21%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

BUY
$74.84 - $88.15 $3,816 - $4,495
51 Added 1.93%
2,698 $224,000
Q4 2023

Feb 06, 2024

BUY
$69.57 - $78.12 $182,760 - $205,221
2,627 Added 13135.0%
2,647 $207,000
Q3 2023

Nov 13, 2023

BUY
$76.74 - $85.2 $1,074 - $1,192
14 Added 233.33%
20 $2,000
Q2 2023

Aug 15, 2023

BUY
$69.16 - $82.11 $414 - $492
6 New
6 $0
Q1 2022

May 04, 2022

SELL
$71.65 - $87.13 $1,433 - $1,742
-20 Reduced 71.43%
8 $1,000
Q4 2021

Feb 07, 2022

SELL
$77.91 - $88.5 $1,558 - $1,770
-20 Reduced 41.67%
28 $2,000
Q3 2021

Nov 02, 2021

BUY
$68.18 - $87.25 $1,363 - $1,745
20 Added 71.43%
48 $4,000
Q1 2021

May 14, 2021

SELL
$65.32 - $76.01 $2,351 - $2,736
-36 Reduced 56.25%
28 $2,000
Q3 2020

Nov 13, 2020

SELL
$55.23 - $62.39 $43,742 - $49,412
-792 Reduced 92.52%
64 $4,000
Q2 2020

Aug 14, 2020

BUY
$49.45 - $64.16 $4,648 - $6,031
94 Added 12.34%
856 $49,000
Q1 2020

May 07, 2020

SELL
$39.86 - $63.46 $1,036 - $1,649
-26 Reduced 3.3%
762 $39,000
Q4 2019

Feb 06, 2020

BUY
$55.04 - $59.27 $15,080 - $16,239
274 Added 53.31%
788 $45,000
Q3 2019

Nov 05, 2019

SELL
$58.2 - $62.42 $18,856 - $20,224
-324 Reduced 38.66%
514 $30,000
Q2 2019

Aug 08, 2019

BUY
$54.43 - $63.33 $45,612 - $53,070
838 New
838 $52,000

Others Institutions Holding ALC

About ALCON INC


  • Ticker ALC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 490,087,008
  • Market Cap $43.9B
  • Description
  • Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgi...
More about ALC
Track This Portfolio

Track Benjamin F. Edwards & Company, Inc. Portfolio

Follow Benjamin F. Edwards & Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin F. Edwards & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Benjamin F. Edwards & Company, Inc. with notifications on news.